If you could vote on Brexit now which option would you choose?
   

Proteostasis shares surge 12% on FDA "fast track" designation for cystic fibrosis treatment


Proteostasis Therapeutics Inc. PTI, +6.52% shares rose 12.4% in premarket trade Wednesday after the company's combination treatment for cystic fibrosis received a 'fast track' designation from the Food and Drug Administration. Fast track designation is ...

MarketWatch - April 5, 2018

View the full story here: https://www.marketwatch.com/story/proteostasis-shares-surge-12-on-fda-fast-track-designation-for-cystic-fibrosis-treatment-2018-04-04